Clinical trials with gene-editing tools to start: Tang Prize laureate
04/22/2018 06:50 PM
Chinese American biologist and 2016 Tang Prize winner in biopharmaceutical science Feng Zhang (張鋒) said Saturday that initial clinical trials using gene-editing technology to help people with genetic diseases are expected to start this year or next.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Number of black-faced spoonbills in Taiwan falls for first time
04/25/2024 07:32 PM - Cross-Strait
New MAC head signals Lai's wish for stable cross-strait ties: Analysts
04/25/2024 07:06 PM - Society
5 executives at restaurants accused of using expired meat released on bail
04/25/2024 06:10 PM - Politics
Lai urges China to engage with Taiwan's 'democratically elected' government
04/25/2024 05:50 PM - Business
U.S. dollar closes higher on Taipei forex market
04/25/2024 05:26 PM